Clinical Trials Logo

Filter by:
NCT ID: NCT05031715 Recruiting - Clinical trials for Glucose Metabolism Disorders

Berberine and Altered Fasting Glucose

Start date: March 2, 2020
Phase: N/A
Study type: Interventional

The aim of the study was to evaluate the effectiveness of a food supplement, berberine phytosome, which contributes to the control of blood sugar and the improvement of insulin resistance.

NCT ID: NCT05031702 Recruiting - Clinical trials for Postmenopausal Disorder

Camelia Sinensis for Basal Metabolism and Body Composition

Start date: March 8, 2021
Phase: N/A
Study type: Interventional

Camellia Sinensis leaf extract contributes to increasing energy expenditure and calorie consumption by increasing thermogenesis. The purpose of this study is to evaluate the efficacy of Camellia Sinensis on basal metabolism and body composition in overweight women or with obesity in postmenopause.

NCT ID: NCT05030428 Active, not recruiting - Clinical trials for Atherosclerotic Cardiovascular Disease

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

VICTORION-2P
Start date: November 23, 2021
Phase: Phase 3
Study type: Interventional

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).

NCT ID: NCT05030311 Completed - Clinical trials for Chronic Spontaneous Urticaria

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines

REMIX-1
Start date: November 30, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) in adult participants suffering from chronic spontaneous urticaria (CSU) inadequately controlled by H1-antihistamines in comparison to placebo.

NCT ID: NCT05029713 Completed - Sarcopenic Obesity Clinical Trials

Sarcopenic Obesity in Liver Transplanted Patients

OSaLT
Start date: May 10, 2021
Phase:
Study type: Observational

The prevalence of obesity in cirrhotic patients who are candidates for liver transplantation (LT) is increasing, a phenomenon consistent with the increased prevalence of obesity in the general population. On the other hand, in liver patients on the waiting list for transplantation it is often observed sarcopenia. The combination of the two condition is defined sarcopenic obesity, which combines the negative synergy deriving from the two conditions. In this study the investigators will evaluate, for the first time, the prevalence of sarcopenic obesity in subjects undergone LT and determine the possible associated risk factors, particularly the role of immunosuppressive treatment with calcineurin inhibitors in addition to dietary habits and physical activity.

NCT ID: NCT05029505 Recruiting - Clinical trials for Patellar Instability

The Caton-Deschamps Index Reliability in Patellar Stabilization Surgery.

Start date: July 12, 2021
Phase:
Study type: Observational

Recurrent patellofemoral instability is a multifactorial pathology based on limb alignment, soft tissue constraints as well as patella and trochlear groove abnormal anatomy. For a correct and effective surgical approach, an accurate radiological evaluation is essential, which consists of the evaluation of three main factors of instability: trochlear dysplasia, abnormal height of the patella and pathological distance of the anterior tibial apophysis and trochlear throat (TA-GT). Concerning patellar height, one of the most used methods is the calculation of the Caton-Deschamps radiographic index. However, to date there is no study that certifies its reproducibility and reliability from a pre-operative assessment and planning perspective.

NCT ID: NCT05029323 Recruiting - Syncope Clinical Trials

Validation of a Novel Simplified Head up Tilt Test (HUTT) Protocol Versus the Conventional Protocol

Start date: January 7, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to compare the positivity rate associated with a novel simplified Tilt-Table (TT) test protocol versus the conventional TT protocol

NCT ID: NCT05028660 Recruiting - Clinical trials for Muscle-Invasive Bladder Carcinoma

AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

AUR93A
Start date: July 21, 2021
Phase:
Study type: Observational

AURORAX-0093A (AUR93A) is a pilot cohort observational study that will explore the use of urine and plasma glycosaminoglycans (GAGs) to prognosticate muscle-invasive bladder cancer (MIBC) patients elected for neo-adjuvant chemotherapy (NAC).

NCT ID: NCT05028647 Completed - Dyslexia Clinical Trials

VAlidation of an Educational Technological Tool for Dyslexic Adolescents: an Open Controlled Study

FORDYS
Start date: April 9, 2021
Phase: N/A
Study type: Interventional

Virtual reality (VR) and augmented reality (AR) are gaining importance in the rehabilitation programs for learning disabilities. The project will test tolerability and efficacy of a VR/AR specially developed tool to improve reading abilities of adolescents with dyslexia aged 10-16

NCT ID: NCT05028348 Recruiting - Multiple Myeloma Clinical Trials

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

Start date: April 19, 2022
Phase: Phase 3
Study type: Interventional

This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR-QoL) of SPd versus EloPd in pomalidomide-naïve patients with MM who have received 1 to 4 prior anti-MM regimens and been treated with an immunomodulatory imide drug (IMiD), proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody (mAb).